Larazotide eased symptoms in phase II celiac trial
Publish date: May 12, 2014
AT DDW 2014
The study was supported by Alba Therapeutics. Dr. Murray reported serving as a consultant to or on the advisory boards of nearly a dozen pharmaceutical companies, Alba not among them. Dr. Lebwohl reported having no financial conflicts.
